These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 23143508)

  • 61. Office practice of osteoporosis evaluation.
    Lacativa PG; de Farias ML
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):674-84. PubMed ID: 17117293
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Guidelines for the diagnosis, prevention and management of osteoporosis.
    Rossini M; Adami S; Bertoldo F; Diacinti D; Gatti D; Giannini S; Giusti A; Malavolta N; Minisola S; Osella G; Pedrazzoni M; Sinigaglia L; Viapiana O; Isaia GC
    Reumatismo; 2016 Jun; 68(1):1-39. PubMed ID: 27339372
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Markers of bone turnover: consideration on their clinical application in osteoporosis.
    Cantatore FP; Pipitone V
    Panminerva Med; 1999 Sep; 41(3):247-51. PubMed ID: 10568124
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Protein Markers in Osteoporosis.
    Porcelli T; Pezzaioli L; Delbarba A; Maffezzoni F; Cappelli C; Ferlin A
    Protein Pept Lett; 2020; 27(12):1253-1259. PubMed ID: 32334493
    [TBL] [Abstract][Full Text] [Related]  

  • 65. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada.
    Brown JP; Josse RG;
    CMAJ; 2002 Nov; 167(10 Suppl):S1-34. PubMed ID: 12427685
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Biochemical markers in osteoarthritis with lessons learned from osteoporosis.
    Karsdal MA; Henriksen K; Bay-Jensen AC
    Clin Exp Rheumatol; 2019; 37 Suppl 120(5):73-87. PubMed ID: 31621570
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Using biochemical markers of bone turnover in clinical practice.
    Singer FR; Eyre DR
    Cleve Clin J Med; 2008 Oct; 75(10):739-50. PubMed ID: 18939390
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Daily practice using the guidelines for prevention and treatment of osteoporosis. How do we realize the bone quality in routine practice using Japanese guideline for osteoporosis prevention and treatment?].
    Saito M
    Clin Calcium; 2008 Aug; 18(8):1104-13. PubMed ID: 18677047
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Metabolomics and Its Application in the Development of Discovering Biomarkers for Osteoporosis Research.
    Lv H; Jiang F; Guan D; Lu C; Guo B; Chan C; Peng S; Liu B; Guo W; Zhu H; Xu X; Lu A; Zhang G
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27918446
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Daily practice using the guidelines for prevention and treatment of osteoporosis. Fracture risk assessment with Japanese guideline].
    Hosoi T
    Clin Calcium; 2008 Aug; 18(8):1084-8. PubMed ID: 18677044
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical use of serum and urine bone markers in the management of osteoporosis.
    Srivastava AK; Vliet EL; Lewiecki EM; Maricic M; Abdelmalek A; Gluck O; Baylink DJ
    Curr Med Res Opin; 2005 Jul; 21(7):1015-26. PubMed ID: 16004668
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Clinical usefulness of bone turnover markers in the management of osteoporosis].
    Yano S
    Rinsho Byori; 2013 Sep; 61(9):852-9. PubMed ID: 24369600
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Significance of Bone Turnover Marker Measurement in the Treatment of Osteoporosis].
    Miura M; Satoh Y
    Yakugaku Zasshi; 2019; 139(1):27-33. PubMed ID: 30606924
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Biochemical markers of bone turnover for treatment of osteoporosis].
    Fujiyama K; Kiriyama T
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():256-62. PubMed ID: 11979917
    [No Abstract]   [Full Text] [Related]  

  • 75. Information needs in the management of osteoporosis in family practice: an illustration of the failure of the current guideline implementation process.
    Jaglal SB; McIsaac WJ; Hawker G; Carroll J; Jaakkimainen L; Cadarette SM; Cameron C; Davis D
    Osteoporos Int; 2003 Aug; 14(8):672-6. PubMed ID: 12879224
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Consensus and controversy regarding osteoporosis in the pediatric population.
    Bachrach LK
    Endocr Pract; 2007 Sep; 13(5):513-20. PubMed ID: 17872354
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Management recommendations for osteoporosis in clinical guidelines.
    Wang M; Bolland M; Grey A
    Clin Endocrinol (Oxf); 2016 May; 84(5):687-92. PubMed ID: 26668071
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Biochemical markers of bone turnover for the clinical investigation of osteoporosis.
    Delmas PD
    Osteoporos Int; 1993; 3 Suppl 1():81-6. PubMed ID: 8461587
    [TBL] [Abstract][Full Text] [Related]  

  • 79. How useful are measures of BMD and bone turnover?
    Miller PD; Hochberg MC; Wehren LE; Ross PD; Wasnich RD
    Curr Med Res Opin; 2005 Apr; 21(4):545-54. PubMed ID: 15899103
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [The role of bone metabolic markers in qualification for treatment of osteoporosis. Results of POMOST study].
    Przedlacki J; Bartoszewicz Z; Ksiezopolska-Orłowska K; Kondracka A; Grodzki A; Bartuszek T; Bartuszek D; Swirski A; Loth E; Musiał J; Luczak E; Teter P; Lasiewicki A; Walkiewicz A; Drozdowska-Rusinowicz I
    Endokrynol Pol; 2009; 60(1):25-32. PubMed ID: 19224502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.